Outlook Therapeutics OTLK
NASDAQ OTLK
$0.56 +0.04 (+7.94%)
At close: Oct 21, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Receivables - Other (2015 - 2016)

Updated

Outlook Therapeutics' Receivables - Other was $43,350 in fiscal Q3 2016 (quarter ended Jun 30, 2016), up 0.4% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Receivables - Other (2015 - 2016) Analysis & Trends

At the end of FY2015 (ended Sep 30, 2015), Receivables - Other at Outlook Therapeutics came in at $117,506.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Outlook Therapeutics 77.51 Mn 41.76 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 43,350.00
Mar 31, 2016 43,187.00
Sep 30, 2015 117,506.00
API Access

Outlook Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=OTLK&period=max&api_key=YOUR_API_KEY